Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CHATTEM NON-CRP PAMPRIN SKUs CONSTITUTE MORE THAN 75% OF BRAND SALES

This article was originally published in The Tan Sheet

Executive Summary

CHATTEM NON-CRP PAMPRIN SKUs CONSTITUTE MORE THAN 75% OF BRAND SALES in 1993, according to sales data in Consumer Product Safety Commission documents supporting the commission's case against the company. CPSC said that the package sizes of Maximum Strength Pamprin Tablets, Maximum Strength Pamprin Caplets, and Pain Relief Pamprin Caplets that do not include child-resistant packaging features account for 86%, 75.7%, and 89.6%, respectively, of each Pamprin product's 1993 sales.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082504

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel